Clinical trials
Completed Lymphoma, T-Cell trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
108 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 2 |
| 2005 | 1 |
| 2006 | 4 |
| 2007 | 4 |
| 2008 | 5 |
| 2009 | 8 |
| 2010 | 7 |
| 2011 | 9 |
| 2012 | 4 |
| 2013 | 10 |
| 2014 | 4 |
| 2015 | 6 |
| 2016 | 3 |
| 2017 | 8 |
| 2018 | 8 |
| 2019 | 8 |
| 2020 | 3 |
| 2021 | 2 |
| 2022 | 4 |
| 2023 | 1 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 108 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 14 |
| M.D. Anderson Cancer Center | 9 |
| Memorial Sloan Kettering Cancer Center | 4 |
| Acrotech Biopharma Inc. | 3 |
| Fred Hutchinson Cancer Center | 3 |
| Samsung Medical Center | 3 |
| Seagen Inc. | 3 |
| Celgene | 2 |
| City of Hope Medical Center | 2 |
| Masonic Cancer Center, University of Minnesota | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma, T-Cell | 108 |
| Lymphoma | 32 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 25 |
| Lymphoma, Large-Cell, Anaplastic | 22 |
| Lymphoma, Mantle-Cell | 22 |
| Lymphoma, Non-Hodgkin | 22 |
| Lymphoma, B-Cell | 21 |
| Lymphoma, T-Cell, Cutaneous | 21 |
| Hodgkin Disease | 20 |
| Lymphoma, Follicular | 19 |
Trials
Showing 26 to 50 of 108. Each trial links to its page on Pharma Observatory.
8 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.